Navigation Links
Elliott Broidy Expands Role in Los Angeles Civics with Support of Stem Cell Research Program
Date:7/19/2013

LOS ANGELES, July 19, 2013 /PRNewswire/ -- Elliott Broidy attended a conference on July 12 at the Eli and Edythe Broad Center aimed to dispel misconceptions and discussed advances in the burgeoning field of stem cell research. Another prominent topic of discussion was the newly formed Early Investigator High School Program (EIHS), which is designed to ensure the future of stem cell work with internships for high school students.

With the fledgling program facing constraints to admit qualified students of all economic backgrounds, the EIHS received a timely boost in support from a Los Angeles native attending the forum.

Philanthropist Elliott Broidy was in attendance to discuss the opportunities and challenges facing stem cell researchers. His attendance was preceded by the announcement that he will fund scholarships to enable gifted youth from disadvantaged situations to attend the summertime EIHS.

Elliott Broidy, Chairman and CEO of Broidy Capital Management, is a USC alumnus involved with various Los Angeles based charitable organizations. These groups include the Aviva Family and Children's Services, Simon Wiesenthal Center, Chai Lifeline, and the USC Marshall School of Business.

EIHS leadership hopes to make the nascent field of stem cell research accessible to all, according to a letter thanking forum attendees. The release touts that initial results indicate stem cell
'/>"/>

SOURCE Cyberactive Marketing
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Removing Barriers: L.A. Philanthropist Elliott Broidy Gives Top Performing Inner City High School Kids Opportunity to Attend Elite Stem Cell Camp
2. PharmSource CMO-CDMO Database Expands Coverage to Include Approved Pharmaceutical Products: Intelligence Resource for Analyzing Bio/Pharmaceutical Contract Manufacturing
3. DoctorDirectory Expands Team for IncreaseRx
4. Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma
5. Cellular Dynamics International Expands MyCell Products Line with Disease Models, Genetic Engineering Patents
6. Julabo USA Inc. Expands Its Line of Compact and Economic Cooling Circulators
7. Rocky Mountain Biologicals Expands Custom Serum Filtration Facility
8. GenoSpace Expands Its Management Team by Appointing Daniel Meyer as Chief Financial Officer
9. GLM Displays Expands Its Line of Formulate Fabric Displays with the Vibe 10ft Display
10. Shire to Acquire SARcode Bioscience, Expands Presence in Ophthalmology
11. Leading Chemical Manufacturer Expands Biobased Offering through Unique Distribution of Proven Green Spill Absorbent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... GENEVA , July 11, 2014 ... pleased to announce the appointment of John P. ... Campus Biotech   in  Geneva . ... on Campus Biotech in Geneva , ... internationally recognised neuroscientists. John P. Donoghue , founder ...
(Date:7/10/2014)... 10, 2014 Women in the ... to an additional family planning option. Sayana® Press ... at all levels of the health system and ... a widely used contraceptive—Pfizer’s Depo-Provera® (depot medroxyprogesterone acetate)—with ... is the first of four African countries expected ...
(Date:7/10/2014)... Terascala, the industry leader in HPC ... former vice president of product management for Flexera Software, ... marketing. Terascala’s software when combined with leading compute and ... performance and most reliable solutions for processing big data. ... expansion and broaden its product portfolio. His leadership in ...
(Date:7/10/2014)... July 10, 2014 EvoDerma ’s NOOME ... This rejuvenating device now comes with a second treatment cup ... time. , The new cup is thinner on the edges ... to target rough, thin and uneven surfaces on the face, ... for a stimulating treatment on areas such as the cheeks ...
Breaking Biology Technology:John P. Donoghue is Taking the Lead at the Wyss Center and is Appointed Professor at EPFL and University of Geneva 2John P. Donoghue is Taking the Lead at the Wyss Center and is Appointed Professor at EPFL and University of Geneva 3Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 2Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 3Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 4Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 5Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 6Terascala Expands Executive Team 2Terascala Expands Executive Team 3Introducing a New Bonus Treatment Cup for EvoDerma’s NOOME Anti-Aging Motion 2
... Inc. (Nasdaq: EVVV ),a global endovascular device ... its Board of Directors effective immediately. , ... president and chief executive officer of CCS,Medical, a privately ... diseases such as diabetes, wound care, urology and respiratory,disorders. ...
... and PHILADELPHIA, Dec. 3 GlaxoSmithKline,(LSE/NYSE: GSK ) ... a,pending lawsuit in the previously announced tender offer to purchase ... Inc.,(Nasdaq: GNLB ), for $1.30 per share in ... It is a condition to ...
... Dec. 3 CeloNova BioSciences, Inc., announced,today that ... is commercializing the,CATANIA(TM) Coronary Stent System with NanoThin ... any stent thrombosis in clinical studies. It is ... now some Middle,Eastern countries with aggressive world-wide expansion ...
Cached Biology Technology:ev3 Inc. Appoints John L. Miclot to Board of Directors 2GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc. 2GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc. 3CeloNova BioSciences Commercializes CATANIA(TM) Coronary Stent With NanoThin Polyzene(R)-F in Europe and Middle East 2CeloNova BioSciences Commercializes CATANIA(TM) Coronary Stent With NanoThin Polyzene(R)-F in Europe and Middle East 3
(Date:7/11/2014)... July 3, 2014, Shenzhen, China Researchers from Salk ... for the first time evaluated the safety and ... and successfully developed a new method, TALEN-HDAdV, which ... pluripotent stem cell (hiPSC). This study published online ... important theoretical foundation for stem cell-based gene therapy. ...
(Date:7/11/2014)... Researchers have pioneered a revolutionary new way to ... Virtual Finger, allows scientists to move through digital ... using the flat surface of their computer screens. ... orders of magnitude more efficient, saving time, money ... areas of experimental biology. The software and its ...
(Date:7/11/2014)... that under the normal circumstances, astrocytes participate ... neuronal environment, and exhibit therapeutic and repairing ... Previous studies have found that nerve cells ... induction have reduced viability, which produces influences ... Yuan, Kailuan General Hospital, Hebei United University, ...
Breaking Biology News(10 mins):A new genome editing method brings the possibility of gene therapies closer to reality 2Virtual finger enables scientists to navigate and analyze complex 3D images 2
... learning to swim? Thrashing around, floundering, until suddenly it ... of doggy-paddle propel you away from your parent's arms. ... swimmers. Actually, fish larvae are pretty feeble when it ... Dr Ulrike Müller from Wageningen University studies how fish ...
... breast cancer is the lack of inexpensive, early detection ... Michigan hope to change that by developing a device ... with breast cancer. The team won a Breast Cancer ... reward research proposals that could lead to critical advancements ...
... show that regular use of popular prescription pain relievers may ... percent and may offer similar benefit in the prevention of ... were released today at the annual meeting of the American ... believe this is the first study to show that selective ...
Cached Biology News:Even fish don't swim well when they're young! 2Researchers win money to develop breath test to detect breast cancer 2COX-2 inhibitors significantly reduce risk of cancer 2
...
...
... is >95%NEN Radiolabeled Ligands\n\nReceptor-related research has long ... new radiolabeled ligands selected to keep pace ... range of products and services for receptor ... state-of-the-art radioligands. If you do not find ...
... DNase (patent pending) was developed using a protein ... the DNA binding pocket of wild-type DNase I. ... protein for DNA. The result is a versatile ... DNA, and an ability to maintain at least ...
Biology Products: